NCT05619406 (SIBSGENOMICS) is a NA clinical trial of Riskometer Application in Hypertension, sponsored by University College Hospital, Ibadan.

Who is sponsoring NCT05619406?

NCT05619406 is sponsored by University College Hospital, Ibadan.

What drugs are being tested in NCT05619406?

Interventions in NCT05619406: Riskometer Application, Routine Clinic Therapy.

What condition does NCT05619406 study?

NCT05619406 studies Hypertension, Adult, Dyslipidemias, Physical Inactivity, Diabetes, Alcohol Consumption.

Is NCT05619406 still recruiting?

NCT05619406 is currently status unknown. Last updated 16 November 2022.

Last reviewed 2022-11-16 · How we verify

NCT05619406: SIBSGENOMICS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Systematic Investigation of Blacks With Stroke - GENOMICS

Status unknown NA Last updated 16 November 2022

What this trial tests

NA trial testing Riskometer Application in Hypertension in 100 participants. Status unknown.

Timeline

20 August 2022

Primary endpoint
6 November 2022

15 December 2022

Quick facts

Lead sponsor	University College Hospital, Ibadan
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	100
Start date	20 August 2022
Primary completion	6 November 2022
Estimated completion	15 December 2022
Sites	3 locations across Ghana, Nigeria

Drugs / interventions tested

Riskometer Application
Routine Clinic Therapy

Conditions studied

Hypertension — all drugs for Hypertension →
Adult — all drugs for Adult →
Dyslipidemias — all drugs for Dyslipidemias →
Physical Inactivity — all drugs for Physical Inactivity →

Sponsor

University College Hospital, Ibadan

Who can join

18 and older, any sex, with Hypertension or Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goal of SIBS-GENOMICS is to utilize the best available contextual data on stroke in Africa to develop \& validate stroke risk estimation models, translate the best model into a mobile phone app and conduct a randomized control trial of the app with a co-created motivational education video, to determine their effectiveness for improvement of stroke risk factor awareness and global risk reduction among Africans.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of an Educational Intervention for Primary Stroke Risk Reduction in Ghana and Nigeria: Pilot Randomized Controlled Trial.
Sarfo FS, Akinyemi JO, Obiako R, Nichols M, et al · · 2023 · cited 13× · PMID 37139815 · DOI 10.1161/strokeaha.123.042618

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other University College Hospital, Ibadan trials

Trials by the same sponsor.

NCT05936164 — Nigeria Atrial Fibrillation Registry · not yet recruiting
NCT04487496 — Determinants of Access to Emergency Surgery at the University College Hospital, Ibadan · completed
NCT03599596 — Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine · Phase 1 · unknown
NCT03744494 — Cosmetic Appeal, HRQoL and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer · NA · completed
NCT05936957 — The Ibadan Acute and Chronic Heart Failure Project · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05619406 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University College Hospital, Ibadan
Last refreshed: 16 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05619406.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing